What are the Challenges in Targeting the Androgen Receptor?
One major challenge is the development of resistance to AR-targeted therapies. Cancer cells can adapt through several mechanisms, such as splicing variants of the AR that remain active without androgens, increased expression of AR, or activation of alternative pathways that bypass the need for AR signaling. Understanding these resistance mechanisms is crucial for developing next-generation therapies.
